H.C. Wainwright raises Travere Therapeutics price target to $67
H.C. Wainwright raises Travere Therapeutics price target to $67
H.C. Wainwright raises Travere Therapeutics price target to $67
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.